BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2016 2:15:00 PM | Browse: 1206 | Download: 1739
 |
Received |
|
2015-07-28 14:22 |
|
Peer-Review Started |
|
2015-07-29 15:34 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2015-11-03 09:00 |
|
Revised |
|
2015-12-05 03:50 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-12-28 14:07 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-01-11 15:44 |
|
Articles in Press |
|
2016-01-11 15:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-03-21 10:23 |
|
Publish the Manuscript Online |
|
2016-03-30 14:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Crystal S Seldon, Lauren E Colbert, William A Hall, Sarah B Fisher, David S Yu and Jerome C Landry |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Center for Advancing Translational Sciences of the National Institutes of Health |
ULl TR000454 (to Dr. Colbert and Dr. Fisher) |
| National Center for Advancing Translational Sciences of the National Institutes of Health |
TLlTR000456 (to Dr. Colbert) |
| Pancreatic Cancer Action Network (Pan-CAN)&solAmerican Association for Cancer Research (AACR) |
16982 (to Dr. Yu) |
| Department of Defense (DOD)/ Peer Reviewed Cancer Research Program (PRCRP) |
CA110535 (to Dr. Yu) |
| Georgia Cancer Coalition |
11072 (to Dr. Yu) |
|
| Corresponding Author |
Jerome C Landry, MD, MBA, Assistant Professor, Department of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road, NE, Suite C3008, Atlanta, GA 30322, United States. jland01@emory.edu |
| Key Words |
Chromodomain-helicase-DNA binding protein 5; Chromodomain-helicase-DNA binding protein 7; Mixed lineage kinase domain-like protein; Pancreatic adenocarcinoma; Biomarker |
| Core Tip |
Pancreatic cancer is one of the deadliest cancers with a very poor prognosis. Recently, there has been a significant increase in studies and research directed towards identifying potential biomarkers that can be used to diagnose and provide prognostic information for pancreatic cancer. We focused on 3 biomarkers involved in the DNA damage response pathway and the necroptosis pathway: Chromodomain-helicase-DNA binding protein 5, chromodomain-helicase-DNA binding protein 7, and mixed lineage kinase domain-like protein. Based on the data presented, these biomarkers warrant further investigation. |
| Publish Date |
2016-03-30 14:14 |
| Citation |
Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas. World J Gastrointest Oncol 2016; 8(4): 358-365 |
| URL |
http://www.wjgnet.com/1948-5204/full/v8/i4/358.htm |
| DOI |
http://dx.doi.org/10.4251/wjgo.v8.i4.358 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
